Dr Ankur Bahl is a highly skilled cancer specialist who has more than 15+ years of rich experience in this field. He is an alumnus of Maulana Azad Medical CollegeDelhi from where he did his MBBS, followed by MD Medicine. He has done his DM Medical Oncology from the prestigious AIIMS New Delhi. He has also completed a course on Adverse Drug Reactions, Drug Interactions and Pharmacovigilance at the University of Oxford UK. Dr Bahl holds clinical expertise in immunotherapy, targeted therapies in combination with Chemotherapy, Hormonal Therapy, and Supportive and Palliative Care. He is the lead author of the largest real-world Indian data on targeted therapy(Cetuxmab) in Head & Neck cancer, Acute Myeloid Leukaemia Treatment, Human Papilloma Virus trends in the Indian Population etc. He is also the lead founder of various innovative oncology educational platforms and networks(International and national) Evidence-based debates in oncology, Live Oncology Tumour boards, Master Classes and workshops in oncology.